Trial Profile
Treatment of Thromboangiitis Obliterans (Buerger's Disease) With Bosentan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2016
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Thromboangiitis obliterans
- Focus Therapeutic Use
- 19 Aug 2016 New trial record